HHS challenges Vertex Pharmaceuticals' fertility services program, alleging violations of anti-kickback laws linked to its ...

Shionogi’s S-892216 is being developed as a pre-exposure prophylaxis (PrEP) drug for Covid-19. Credit: seksan Mongkhonkhamsao ...

That proposed rule sparked backlash from health care providers, patient advocacy groups and telehealth advocates who have argued telehealth has expanded access to treatment for people who may not ...

Ozempic and Wegovy, Novo Nordisk’s GLP-1 drugs that treat diabetes and obesity, are on the list. Astellas Pharma’s prostate cancer drug, Xtandi, is also on the list — alongside AstraZeneca’s cancer ...

The FDA established its accelerated approval program in 1992 to allow drugs to reach the market quickly for life-threatening ...

Roll Call reports that the newly finalized rule will allow for health care providers who have not seen a patient in person to prescribe six months’ worth of buprenorphine via telehealth. Also in ...

HHS is asking the court to affirm its Office of Inspector General's finding that paying for fertility services would run ...

Of the 24 drugs, three approvals deviated from the others -- aducanumab; the synthetic hormone hydroxyprogesterone caproate ...

Along with its gene editing therapy Casgevy, Vertex is offering fertility preservation support for its patients—a program ...

Cedars-Sinai Medical Center enters voluntary agreement with HHS and OCR to address civil rights violations and improve maternal health for Black women.

WASHINGTON — The Biden administration Wednesday finalized a long-awaited rule laying out how some health care providers can prescribe gold-standard opioid use disorder treatments through ...